Movement Alert｜Cardinal Health Rises 5.78% in Regular Trading, Q4 Earnings Beat Expectations with $5 Billion Buyback Plan

Market Focus08-11 21:51

On August 11, Cardinal Health rose 5.78% in regular trading, trading at $248.875/share, with turnover of approximately $120 million. The rally was driven by a strong fiscal Q4 earnings beat combined with a substantial new share repurchase authorization.

Cardinal Health reported fiscal Q4 non-GAAP earnings of $2.91 per diluted share, significantly exceeding the FactSet consensus estimate of $2.42 and up from $2.08 a year earlier. Revenue for the quarter ended June 30 was $63.67 billion, up from $60.16 billion year-over-year, though slightly below the $65.15 billion analyst estimate. More critically, the company issued fiscal 2027 adjusted EPS guidance of $12.40 to $12.60, well above the Street consensus of $12.08. Simultaneously, the board approved an incremental $5 billion stock repurchase authorization, substantially enhancing the company's capital return capacity. The company also maintained its quarterly dividend at $0.5158 per share. The combination of a 20% earnings beat, above-consensus forward guidance, and a sizable buyback commitment collectively fueled investor enthusiasm.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187413053?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-11 21:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187413053","market":"us","top_or_hot":-1,"title":"Movement Alert｜Cardinal Health Rises 5.78% in Regular Trading, Q4 Earnings Beat Expectations with $5 Billion Buyback Plan","media":"Market Focus","content":"<p><p>On August 11, Cardinal Health rose 5.78% in regular trading, trading at $248.875/share, with turnover of approximately $120 million. The rally was driven by a strong fiscal Q4 earnings beat combined with a substantial new share repurchase authorization.</p><p>Cardinal Health reported fiscal Q4 non-GAAP earnings of $2.91 per diluted share, significantly exceeding the FactSet consensus estimate of $2.42 and up from $2.08 a year earlier. Revenue for the quarter ended June 30 was $63.67 billion, up from $60.16 billion year-over-year, though slightly below the $65.15 billion analyst estimate. More critically, the company issued fiscal 2027 adjusted EPS guidance of $12.40 to $12.60, well above the Street consensus of $12.08. Simultaneously, the board approved an incremental $5 billion stock repurchase authorization, substantially enhancing the company's capital return capacity. The company also maintained its quarterly dividend at $0.5158 per share. The combination of a 20% earnings beat, above-consensus forward guidance, and a sizable buyback commitment collectively fueled investor enthusiasm.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Cardinal Health Rises 5.78% in Regular Trading, Q4 Earnings Beat Expectations with $5 Billion Buyback Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Cardinal Health Rises 5.78% in Regular Trading, Q4 Earnings Beat Expectations with $5 Billion Buyback Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-11 21:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 11, Cardinal Health rose 5.78% in regular trading, trading at $248.875/share, with turnover of approximately $120 million. The rally was driven by a strong fiscal Q4 earnings beat combined with a substantial new share repurchase authorization.</p><p>Cardinal Health reported fiscal Q4 non-GAAP earnings of $2.91 per diluted share, significantly exceeding the FactSet consensus estimate of $2.42 and up from $2.08 a year earlier. Revenue for the quarter ended June 30 was $63.67 billion, up from $60.16 billion year-over-year, though slightly below the $65.15 billion analyst estimate. More critically, the company issued fiscal 2027 adjusted EPS guidance of $12.40 to $12.60, well above the Street consensus of $12.08. Simultaneously, the board approved an incremental $5 billion stock repurchase authorization, substantially enhancing the company's capital return capacity. The company also maintained its quarterly dividend at $0.5158 per share. The combination of a 20% earnings beat, above-consensus forward guidance, and a sizable buyback commitment collectively fueled investor enthusiasm.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CAH","symbol_name":"卡地纳健康","start_time":0,"source_url":"","article_id":"1187413053","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187413053","pubTimestamp":1786456267,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 11, Cardinal Health rose 5.78% in regular trading, trading at $248.875/share, with turnover of approximately $120 million. The rally was driven by a strong fiscal Q4 earnings beat combined...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CAH":"卡地纳健康"},"translate_title":"走势警报|Cardinal Health 常规交易上涨 5.78%，第四季度盈利超出预期，并计划 50 亿美元回购","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CAH":1},"content_text":"On August 11, Cardinal Health rose 5.78% in regular trading, trading at $248.875/share, with turnover of approximately $120 million. The rally was driven by a strong fiscal Q4 earnings beat combined with a substantial new share repurchase authorization.Cardinal Health reported fiscal Q4 non-GAAP earnings of $2.91 per diluted share, significantly exceeding the FactSet consensus estimate of $2.42 and up from $2.08 a year earlier. Revenue for the quarter ended June 30 was $63.67 billion, up from $60.16 billion year-over-year, though slightly below the $65.15 billion analyst estimate. More critically, the company issued fiscal 2027 adjusted EPS guidance of $12.40 to $12.60, well above the Street consensus of $12.08. Simultaneously, the board approved an incremental $5 billion stock repurchase authorization, substantially enhancing the company's capital return capacity. The company also maintained its quarterly dividend at $0.5158 per share. The combination of a 20% earnings beat, above-consensus forward guidance, and a sizable buyback commitment collectively fueled investor enthusiasm.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187413053","isCrawlerRequest":true}